Literature DB >> 27659010

Detection of herpes simplex virus type 2 (HSV-2) -specific cell-mediated immune responses in guinea pigs during latent HSV-2 genital infection.

Clarice L Perry1, Brianne N Banasik1, Summer R Gorder1, Jingya Xia2, Sarah Auclair3, Nigel Bourne4, Gregg N Milligan5.   

Abstract

Genital infections with herpes simplex virus type 2 (HSV-2) are a source of considerable morbidity and are a health concern for newborns exposed to virus during vaginal delivery. Additionally, HSV-2 infection diminishes the integrity of the vaginal epithelium resulting in increased susceptibility of individuals to infection with other sexually transmitted pathogens. Understanding immune protection against HSV-2 primary infection and immune modulation of virus shedding events following reactivation of the virus from latency is important for the development of effective prophylactic and therapeutic vaccines. Although the murine model of HSV-2 infection is useful for understanding immunity following immunization, it is limited by the lack of spontaneous reactivation of HSV-2 from latency. Genital infection of guinea pigs with HSV-2 accurately models the disease of humans including the spontaneous reactivation of HSV-2 from latency and provides a unique opportunity to examine virus-host interactions during latency. Although the guinea pig represents an accurate model of many human infections, relatively few reagents are available to study the immunological response to infection. To analyze the cell-mediated immune response of guinea pigs at extended periods of time after establishment of HSV-2 latency, we have modified flow-cytometry based proliferation assays and IFN-γ ELISPOT assays to detect and quantify HSV-specific cell-mediated responses during latent infection of guinea pigs. Here we demonstrate that a combination of proliferation and ELISPOT assays can be used to quantify and characterize effecter function of virus-specific immune memory responses during HSV-latency. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell-mediated immunity; Genital tract; Guinea pig; HSV-2 latency; IFN-gamma; T cell proliferation

Mesh:

Substances:

Year:  2016        PMID: 27659010      PMCID: PMC5125880          DOI: 10.1016/j.jim.2016.09.004

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  27 in total

1.  Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2.

Authors:  X Da Costa; M F Kramer; J Zhu; M A Brockman; D M Knipe
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Immunological evaluation of mannosylated chitosan nanoparticles based foot and mouth disease virus DNA vaccine, pVAC FMDV VP1-OmpA in guinea pigs.

Authors:  Raj Kishore Nanda; Irshad Ahmed Hajam; Bedaso Mammo Edao; Kalaivanan Ramya; Mageswary Rajangam; Shanmugam Chandra Sekar; Kondabattula Ganesh; Veerakyathappa Bhanuprakash; Subodh Kishore
Journal:  Biologicals       Date:  2014-03-20       Impact factor: 1.856

3.  Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected.

Authors:  Nigel Bourne; Gregg N Milligan; Lawrence R Stanberry; Rachael Stegall; Richard B Pyles
Journal:  J Infect Dis       Date:  2005-11-11       Impact factor: 5.226

4.  Modification of primary and recurrent genital herpes in guinea pigs by passive immunization.

Authors:  Nigel Bourne; Richard B Pyles; David I Bernstein; Lawrence R Stanberry
Journal:  J Gen Virol       Date:  2002-11       Impact factor: 3.891

5.  Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention.

Authors:  F X Mbopi-Kéou; G Grésenguet; P Mayaud; H A Weiss; R Gopal; M Matta; J L Paul; D W Brown; R J Hayes; D C Mabey; L Bélec
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

6.  Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection.

Authors:  R G Rank; M M Sanders
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

7.  Effect of undecylenic acid as a topical microbicide against genital herpes infection in mice and guinea pigs.

Authors:  N Bourne; J Ireland; L R Stanberry; D I Bernstein
Journal:  Antiviral Res       Date:  1999-01       Impact factor: 5.970

8.  Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years--United States, 2005-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-04-23       Impact factor: 17.586

9.  Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs.

Authors:  Megolhubino Terhuja; Paramasivam Saravanan; Ramasamy Periyasamy Tamilselvan
Journal:  Biologicals       Date:  2015-10-20       Impact factor: 1.856

10.  Cell-mediated immunologic responses and recurrent genital herpes in the guinea pig. Effects of glycoprotein immunotherapy.

Authors:  D I Bernstein; C J Harrison; L J Jenski; M G Myers; L R Stanberry
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

View more
  1 in total

1.  Cultivated Human Vaginal Microbiome Communities Impact Zika and Herpes Simplex Virus Replication in ex vivo Vaginal Mucosal Cultures.

Authors:  Megan H Amerson-Brown; Aaron L Miller; Carrie A Maxwell; Mellodee M White; Kathleen L Vincent; Nigel Bourne; Richard B Pyles
Journal:  Front Microbiol       Date:  2019-01-14       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.